Amedisys バランスシートの健全性
財務の健全性 基準チェック /66
Amedisysの総株主資本は$1.2B 、総負債は$353.2Mで、負債比率は29.4%となります。総資産と総負債はそれぞれ$2.1Bと$938.7Mです。 Amedisysの EBIT は$208.9Mで、利息カバレッジ比率8.1です。現金および短期投資は$245.5Mです。
主要情報
29.4%
負債資本比率
US$353.21m
負債
| インタレスト・カバレッジ・レシオ | 8.1x |
| 現金 | US$245.45m |
| エクイティ | US$1.20b |
| 負債合計 | US$938.68m |
| 総資産 | US$2.14b |
財務の健全性に関する最新情報
Does Amedisys (NASDAQ:AMED) Have A Healthy Balance Sheet?
Feb 25
We Think Amedisys (NASDAQ:AMED) Can Stay On Top Of Its Debt
Jul 20Is Amedisys (NASDAQ:AMED) A Risky Investment?
Feb 20These 4 Measures Indicate That Amedisys (NASDAQ:AMED) Is Using Debt Safely
Nov 18Amedisys (NASDAQ:AMED) Could Easily Take On More Debt
Aug 18Recent updates
Final Push For Amedisys As UnitedHealth Awaits Regulatory Clearance
Nov 05Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 41% Discount?
Apr 10Does Amedisys (NASDAQ:AMED) Have A Healthy Balance Sheet?
Feb 25Amedisys (NASDAQ:AMED) Will Be Hoping To Turn Its Returns On Capital Around
Feb 10At US$83.54, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?
Jan 03A Look At The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)
Dec 16Capital Allocation Trends At Amedisys (NASDAQ:AMED) Aren't Ideal
Nov 12Is Now The Time To Look At Buying Amedisys, Inc. (NASDAQ:AMED)?
Sep 19An Intrinsic Calculation For Amedisys, Inc. (NASDAQ:AMED) Suggests It's 38% Undervalued
Sep 04Amedisys: ROIC, Tangible Book Value Each Softening
Aug 24Slowing Rates Of Return At Amedisys (NASDAQ:AMED) Leave Little Room For Excitement
Aug 04Amedisys profit beats by $0.24, revenue misses by $25.23M, 2022 guidance below estimates
Jul 27We Think Amedisys (NASDAQ:AMED) Can Stay On Top Of Its Debt
Jul 20At US$115, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?
Jun 04Returns On Capital At Amedisys (NASDAQ:AMED) Have Stalled
May 05Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 40% Discount?
Apr 20Does Amedisys (NASDAQ:AMED) Deserve A Spot On Your Watchlist?
Apr 06Is Amedisys (NASDAQ:AMED) A Risky Investment?
Feb 20Amedisys (NASDAQ:AMED) Shareholders Will Want The ROCE Trajectory To Continue
Jan 19Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?
Dec 03These 4 Measures Indicate That Amedisys (NASDAQ:AMED) Is Using Debt Safely
Nov 18Amedisys (NASDAQ:AMED) Could Easily Take On More Debt
Aug 18Calculating The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)
Jul 23Amedisys: Strategic Contessa Acquisition Underpins The Home Healthcare Growth Opportunity
Jul 18Under The Bonnet, Amedisys' (NASDAQ:AMED) Returns Look Impressive
Jun 28It Looks Like Shareholders Would Probably Approve Amedisys, Inc.'s (NASDAQ:AMED) CEO Compensation Package
Jun 02Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?
May 24財務状況分析
短期負債: AMEDの 短期資産 ( $579.9M ) が 短期負債 ( $486.0M ) を超えています。
長期負債: AMEDの短期資産 ( $579.9M ) が 長期負債 ( $452.7M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: AMEDの 純負債対資本比率 ( 9% ) は 満足できる 水準であると考えられます。
負債の削減: AMEDの負債対資本比率は、過去 5 年間で39.3%から29.4%に減少しました。
債務返済能力: AMEDの負債は 営業キャッシュフロー によって 十分にカバー されています ( 59.9% )。
インタレストカバレッジ: AMEDの負債に対する 利息支払い は EBIT ( 8.1 x coverage) によって 十分にカバーされています。